Summary
The development and maintenance of hypoxia-induced pulmonary vascular remodeling is not related only to the precapillary pressure increase and shear stress that result from pulmonary vasoconstriction. The recent finding that several mammalian species and mice with 5-HTT deficiency show little hypoxic pulmonary vascular remodeling despite a strong acute hypoxic pressor response suggests that precapillary vasoconstriction may not fully explain the pathophysiology of hypoxic PH. SMC proliferation, the main component of hypoxic pulmonary vascular remodeling, may be best viewed as a process linked to the direct effect of hypoxia on the expression of various genes. Exposure to hypoxia has been shown to downregulate K gn -channel ga subunits in SMCs from pulmonary arteries, thereby decreasing K+ flows and increasing cytoplasmic Ca2+ concentrations in these cells. The effect of hypoxia on gene expression may also alter the balance between pro-and anti-proliferative factors derived from the endothelium. Hypoxia increases the expression of ET-1 and PDGF and decreases the expression of heparan sulfate, prostacyclin synthase, and eNOS synthase. Hypoxia is also known to increase the transcription rate of various genes involved in vascular remodeling through hypoxia-inducible transcription factors. VEGF, which is the product of one of the genes containing functionally important binding sites for HIF-1, may protect against the development of hypoxic PH by stimulating angiogenic processes. Recent experimental findings demonstrate that an increase in the transcription rate of the 5-HTT gene in response to hypoxia plays a major role in pulmonary SMC proliferation. 5-HTT expression is genetically controlled, and a polymorphism in the promoter region of the human gene affects transcriptional activity, the long promoter variant of the gene being associated with increased expression as compared with the short variant. The ability of SMCs to proliferate in response to 5-HT is linked to this functional polymorphism, which may confer susceptibility to various forms of PH in humans, most notably chronic hypoxic PH.
The recent finding that several factors, including 5-HT and ET, are involved not only in experimental hypoxic PH but also in human primary PH suggests that common mechanisms lead to pulmonary vascular remodeling, whatever the inciting causal factor. This provides a strong rationale for actively investigating the mechanisms that underlie the complex vascular changes responsible for the hypoxia-induced pulmonary vascular remodeling. Such studies may identify new molecular pathways involved in various types of PH.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adnot S, Raffestin B, Eddahibi S, Braquet P, and Chabrier P. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 1991; 87: 155–162
Christou H, Yoshida A, Arthur V, Morita T, and Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am. J. Respir. Cell. Mol. Biol. 1998; 18: 768–776.
Eddahibi S, Adnot S, Frisdal E, Levame M, Hamon M, and Raffestin B. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J. Pharmacol. Exp. Ther. 2001; 297: 148–154.
Eddahibi S, Fabre V, Boni C, Martres M, Raffestin B, Hamon M, and Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ. Res. 1999; 84: 329–336.
Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, and Adnot S. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest. 2000; 105: 1555–1562.
Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, and Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension;. J. Clin. Invest. 2001; 108: 1141–1150.
Eddahibi S, Raffestin B, Pham I, Launay JM, Aegerter P, Sitbon M, and Adnot S. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am. J. Physiol. 1997; 272: H1173–H1181.
Hanson WL, Boggs DF, Kay JM, Hofmeister SE, Okada O, and Wagner WW Jr. Pulmonary vascular response of the coati to chronic hypoxia. J. Appl. Physiol. 2000; 88: 981–986.
Humphries DE, Lee SL, Fanburg BL, and Silbert JE. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary endothelial cells. J. Cell Physiol. 1986; 126: 249–253.
Itoh H, Pratt RE, and Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J. Clin. Invest. 1990; 86: 1690–1697.
Katayose D, Ohe M, Yamauchi K, Ogata M, Shirato K, Fujita H, Shibahara S, and Takishima T. Increased expression of PDGF A-and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am. J. Physiol. 1993; 264: L100–L106.
Keegan A, Morecroft I, Smillie D, Hicks MN, and MacLean MR. Contribution of the 5-HT1B-receptor to hypoxia-induced pulmonary hypertension. Circ. Res. 2001; 89: 1231–1239.
Kolpakov V, Rekhter MD, Gordon D, Wang WH, and Kulik TJ. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Circ. Res. 1995; 77: 823–831.
Launay J, Hervé P, Peoc’h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, and Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2Breceptor in pulmonary hypertension. Nat. Med. 2002; 8: 1129–1135.
Lee SL, Wang WW, and Fanburg BL. Association of Tyr Phosphorylation of GTPase — activating protein with mitogenic action of serotonin. Am. J. Physiol. 1997; 272: C223–C230.
Lee S-L, Wang W-W, Finlay GA, and Fanburg BL. Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am. J. Physiol. 1999; 277: L282–L291.
Liu Y, Cox SR, Morita T, and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ. Res. 1995; 77: 638–643.
Lockhart A, Zelter M, Mensch-Dechene J, Antezana G, Paz-Zamora M, Vargas E, and Coudert J. Pressure-flow-volume relationships in pulmonary circulation of normal Highlanders. J. Appl. Physiol. 1976; 41: 449–56.
Madden MC, Vender RL, and Friedman M. Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins. 1986; 31: 1049–1062.
McQuillan LP, Leung GK, Marsden PA, Kostyk SK, and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am. J. Physiol. 1994; 267: H1921–H1927
Means A. Calcium, calmodulin and cell cycle regulation. FEBS lett. 1994; 347: 1–4.
Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, and Chen YF. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. 1995; 268: L95–L100.
Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, and Eddahibi S. Adenovirus-mediated lung VEGF overexpression protects against hypoxic pulmonary hypertension in rats. Am. J. Respir. Cell. Mol. Biol. 2000; 23: 762–771.
Platoshyn O, Yu Y, Golovina V, McDaniel S, Krick S, Li L, Wang J, Tubin L, and Yuan JX-J. Chronic hypoxia decreases Kv channel expression and function in pulmonary artery myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001; 280: L801–L812.
Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, and Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 1979; 236: H818–H827.
Rabinovitch M, Konstam MA, Gamble WJ, Papanicolaou N, Aronovitz MJ, Treves S, and Reid L. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ. Res. 1983; 52: 432–441.
Reeves J and Herget J. Experimental Models of Pulmonary Hypertension. Mount Kisco: Futura Publishing Company, 1984.
Rose F, Grimminger F, Appel J, Pies V, Weissmann N, Fink L, Schmidt S, Krick S, Camenish G, Gassmann N, Seeger W, and Hänze J. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells-role of hypoxia-inducible transcription factors. FASEBJ. 2002; 16: 1660–1661.
Smirnov SV, Robertson TP, Ward JPT, and Aaronson PI. Chronic hypoxia is associated with reduced delayed rectifier K+ current in rat pulmonary muscle cells. Am. J. Physiol. 1994; 266: H365–H370.
Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, McMahon G, Waltenberger J, Voelkel NF, and Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 2001; 15: 427–38.
Tozzi CA, Polani GJ, Harangozo AM, Boyd CD, and Riley DJ. Pressure-induced connective tisssue synthesis in pulmonary artery segments is dependent on intact endothelium. J. Clin. Invest. 1989; 84: 1005–1012.
Xue C and Johns RA. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. Hypertension. 1996; 28: 743–753.
Yet S-F, Perrella MA, Layne MD, Hsieh C-M, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, and Lee M-E. Hypoxia induces severe right ventricular dilation and infarction in heme oxygenase-1 null mice. J. Clin. Invest. 1999; 103: R23–R29.
Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JSK, Wiener CM, Sylvester JT, and Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α J. Clin. Invest. 1999; 103: 691–696.
Zamora MA, Dempsey EC, Walchak SJ, and Stelzner TJ. BQ123, an ETA receptor antagonist, inhibits endothelin-1 mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 1993; 9: 429–433.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Raffestin, B., Adnot, S., Eddahibi, S. (2004). Roles for Vasoconstriction and Gene Expression in Hypoxia-induced Pulmonary Vascular Remodeling. In: Yuan, J.X.J. (eds) Hypoxic Pulmonary Vasoconstriction. Developments in Cardiovascular Medicine, vol 252. Springer, Boston, MA. https://doi.org/10.1007/1-4020-7858-7_28
Download citation
DOI: https://doi.org/10.1007/1-4020-7858-7_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7857-6
Online ISBN: 978-1-4020-7858-3
eBook Packages: Springer Book Archive